Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Neuro-Oncology

• Publication date

  2018-02-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11060-018-2786-8PMID 29423540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)

  2017cited by this paper
• Lovastatin and perillyl alcohol inhibit glioma cell invasion, migration, and proliferation--impact of Ras-/Rho-prenylation.

  2015cited by this paper
• Impact of renin‐angiotensin system blockade on clinical outcome in glioblastoma

  2015cited by this paper
• Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.

  2015cited by this paper
• Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis

  2014cited by this paper
• Statin use after colorectal cancer diagnosis and survival: a population-based cohort study.

  2014cited by this paper
• Statin use and survival following glioblastoma multiforme.

  2014cited by this paper
• Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.

  2014cited by this paper
• Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.

  2014cited by this paper
• Use of statins and the risk of death in patients with prostate cancer.

  2014cited by this paper
• Use of statins and risk of glioma: a nationwide case–control study in Denmark

  2013cited by this paper
• Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells.

  2013cited by this paper
• Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression.

  2013cited by this paper
• Immunohistochemical and histomorphological analysis of rat mammary tumors after simvastatin treatment.

  2012cited by this paper
• HMG CoA reductase inhibitors, NSAIDs and risk of glioma

  2012cited by this paper
• Long-term Use of Angiotensin Converting Enzyme Inhibitors Is Associated With Decreased Incidence of Advanced Adenomatous Colon Polyps

  2011cited by this paper
• Angiotensin II sustains brain inflammation in mice via TGF-beta.

  2010cited by this paper
• The renin–angiotensin system and cancer: old dog, new tricks

  2010cited by this paper
• Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells

  2009cited by this paper
• HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model.

  2009cited by this paper
• EFFECT OF SIMVASTATIN ON GLIOMA CELL PROLIFERATION, MIGRATION, AND APOPTOSIS

  2009cited by this paper
• Induction of apoptosis by lovastatin through activation of caspase-3 and DNase II in leukaemia HL-60 cells.

  2008cited by this paper
• The renin-angiotensin system and malignancy.

  2008cited by this paper
• Perioperative use of statins in noncardiac surgery

  2008cited by this paper
• Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis?

  2008cited by this paper
• Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis

  2007cited by this paper
• Lovastatin-induced apoptosis in human melanoma cell lines

  2005cited by this paper
• Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma

  2005cited by this paper
• Lovastatin‐induced up‐regulation of the BH3‐only protein, Bim, and cell death in glioblastoma cells

  2004cited by this paper
• Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma

  2004cited by this paper
• Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9.

  2003cited by this paper
• Multiple angiotensin receptor subtypes in normal and tumor astrocytes in vitro

  2002cited by this paper
• Angiotensin II induces human TGF-β1 promoter activation: similarity to hyperglycaemia

  2002cited by this paper
• Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study.

  2001cited by this paper
• Lovastatin and phenylacetate induce apoptosis, but not differentiation, in human malignant glioma cells

  2001cited by this paper
• Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro

  2001cited by this paper
• The inhibitory effect of simvastatin on growth in malignant gliomas--with special reference to its local application with fibrin glue spray in vivo.

  2001cited by this paper
• Induction of Apoptosis by Lovastatin through Activation of Caspase‐3 and DNase II in Leukaemia HL‐60 Cells

  2000cited by this paper
• Captopril inhibits glioma cell invasion in vitro: involvement of matrix metalloproteinases.

  1995cited by this paper
• Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

  1985cited by this paper

• Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine

  2026cites this paper
• The Effect of the Concurrent Use of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers on Toxicity and Outcomes in Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis

  2025cites this paper
• Investigation into the synergistic effect of atorvastatin combined with ultrasound stimulation for anti-glioma therapy

  2025cites this paper
• Identification of non-invasive biomarkers associated with glioma hemorrhage

  2025cites this paper
• The Mevalonate Pathway in the Radiation Response of Cancer.

  2025cites this paper
• Drug-Induced Reorganisation of Lipid Metabolism Limits the Therapeutic Efficacy of Ponatinib in Glioma Stem Cells

  2024cites this paper
• Role of renin angiotensin system inhibitors and metformin in Glioblastoma Therapy: a review

  2024cites this paper
• Age-stratified comorbid and pharmacologic analysis of patients with glioblastoma

  2024cites this paper
• Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence

  2023cites this paper
• The effects of statin therapy on brain tumors, particularly glioma: a review

  2023cites this paper
• Statin Use Ameliorates Survival in Oral Squamous Cell Carcinoma—Data from a Population-Based Cohort Study Applying Propensity Score Matching

  2023cites this paper
• Cholesterol metabolism and its implication in glioblastoma therapy

  2022cites this paper
• The use of radiosensitizing agents in the therapy of glioblastoma multiforme—a comprehensive review

  2022cites this paper
• Statins and Gliomas: A Systematic Review of the Preclinical Studies and Meta-Analysis of the Clinical Literature

  2022cites this paper
• Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.

  2021cites this paper
• Dopamine Receptor Antagonists, Radiation, and Cholesterol Biosynthesis in Mouse Models of Glioblastoma.

  2021cites this paper
• Using Elevated Cholesterol Synthesis as a Prognostic Marker in Wilms' Tumor: A Bioinformatic Analysis

  2021cites this paper
• An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma

  2021cites this paper
• The Renin–Angiotensin System in the Tumor Microenvironment of Glioblastoma

  2021cites this paper
• The renin-angiotensin system in central nervous system tumors and degenerative diseases.

  2021influential citation
• A meta-analysis

  2020cites this paper
• New tricks of old drugs: Repurposing non-chemo drugs and dietary phytochemicals as adjuvants in anti-tumor therapies.

  2020cites this paper
• Clinical trials on combination of repurposed drugs and anticancer therapies

  2020cites this paper
• Tumour suppression through modulation of neprilysin signaling: A comprehensive review.

  2020cites this paper
• Effects of statins on brain tumors: a review.

  2020cites this paper
• Impact of atorvastatin loaded exosome as an anti-glioblastoma carrier to induce apoptosis of U87 cancer cells in 3D culture model

  2020cites this paper
• Investigation of typical sartan pharmaceuticals by terahertz absorption spectroscopy and density functional theory

  2020cites this paper
• Newly Diagnosed Glioblastoma: A Review on Clinical Management.

  2019cites this paper
• Current state and future perspective of drug repurposing in malignant glioma.

  2019cites this paper
• The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology.

  2019cites this paper
• Beyond the boundaries of cardiology: still untapped anticancer properties of the cardiovascular system-related drugs.

  2019cites this paper
• Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma-a randomised multicentre trial (ASTER trial). An ANOCEF study.

  2019cites this paper
• Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells

  2019cites this paper
• Can cardiovascular drugs support cancer treatment? The rationale for drug repurposing.

  2019cites this paper
• S‐Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells

  2019cites this paper
• Use of statins or NSAIDs and survival of patients with high-grade glioma

  2018cites this paper